Mersana Therapeutics Inc (MRSN) — Cash Flow Quality Index
Latest as of March 2019:
-1.13x
Mersana Therapeutics Inc (MRSN) has a Cash Flow Quality Index of -1.13x as of March 2019. Operating cash flow of $-24.69 Million is below net income of $21.90 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore MRSN operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
-1.13x
Operating CF / Net Income
Operating Cash Flow
$-24.69 Million
USD
Net Income
$21.90 Million
USD
Data as of
Mar 2019
Most recent filing
Annual Cash Flow Quality Index for Mersana Therapeutics Inc (None–None)
Year-by-year earnings quality comparison for Mersana Therapeutics Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.